Infection Control Business

Any discussion of the business case for infection control (IC) must start by acknowledging that the single most important reason for IC is to prevent morbidity and mortality associated with nosocomial infections. Each year, hundreds and thousands of Americans suffer the consequences of nosocomial infections which can be ranging from the inconvenience of taking extra medications to death. Beyond the human cost is the important economic burden that these infections place on society, including not only the obvious increase in health care resource use but also indirect costs associated with the loss of productivity of patients and their caregivers.

  • Infection Control and Biosafety Products 
  • Articulate Critical Business Strategie
  • Develop Business Strategies
  • High Impact Interventions
  • Increasing Geriatric Population
  • Architecture and Design

Related Conference of Infection Control Business

August 29-30, 2018

4th International Conference on Cytopathology & Histopathology

Boston | Massachusetts | USA
August 31 - September 01, 2018

International Conference and Expo on Dermatopathology and Skin Care

Toronto, Canada
September 17-18, 2018

16th Asia Pacific Pathology Congress

Tokyo, Japan
October 15-16, 2018

3rd International Conference on Internal Medicine & Hospital Medicine

Ottawa, Ontario, Canada
October 18-19, 2018

European Pathology and Infectious Disease Conference

Helsinki, Finland
March 22-23, 2019 |

World Birth Congress

New York, USA
(14 Forums, 2 Days, 1 Event)
April 22-23, 2019

16th Annual Conference on Laboratory Medicine & Pathology

Kuala Lumpur, Malaysia
May 9-10, 2019

17th European Pathology Congress

| Amsterdam, Netherlands

Infection Control Business Conference Speakers

Recommended Sessions

Related Journals

Are you interested in